Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

514 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Review: recent clinical trials in epigenetic therapy.
Oki Y, Issa JP. Oki Y, et al. Rev Recent Clin Trials. 2006 May;1(2):169-82. doi: 10.2174/157488706776876490. Rev Recent Clin Trials. 2006. PMID: 18473969 Review.
Heat shock protein-based cancer vaccines.
Oki Y, Younes A. Oki Y, et al. Expert Rev Vaccines. 2004 Aug;3(4):403-11. doi: 10.1586/14760584.3.4.403. Expert Rev Vaccines. 2004. PMID: 15270645 Review.
JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia.
Jelinek J, Oki Y, Gharibyan V, Bueso-Ramos C, Prchal JT, Verstovsek S, Beran M, Estey E, Kantarjian HM, Issa JP. Jelinek J, et al. Among authors: oki y. Blood. 2005 Nov 15;106(10):3370-3. doi: 10.1182/blood-2005-05-1800. Epub 2005 Jul 21. Blood. 2005. PMID: 16037387 Free PMC article.
Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center.
Oki Y, Kantarjian HM, Zhou X, Cortes J, Faderl S, Verstovsek S, O'Brien S, Koller C, Beran M, Bekele BN, Pierce S, Thomas D, Ravandi F, Wierda WG, Giles F, Ferrajoli A, Jabbour E, Keating MJ, Bueso-Ramos CE, Estey E, Garcia-Manero G. Oki Y, et al. Blood. 2006 Feb 1;107(3):880-4. doi: 10.1182/blood-2005-06-2450. Epub 2005 Aug 25. Blood. 2006. PMID: 16123215
Silencing of bidirectional promoters by DNA methylation in tumorigenesis.
Shu J, Jelinek J, Chang H, Shen L, Qin T, Chung W, Oki Y, Issa JP. Shu J, et al. Among authors: oki y. Cancer Res. 2006 May 15;66(10):5077-84. doi: 10.1158/0008-5472.CAN-05-2629. Cancer Res. 2006. PMID: 16707430
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.
Kantarjian H, Oki Y, Garcia-Manero G, Huang X, O'Brien S, Cortes J, Faderl S, Bueso-Ramos C, Ravandi F, Estrov Z, Ferrajoli A, Wierda W, Shan J, Davis J, Giles F, Saba HI, Issa JP. Kantarjian H, et al. Among authors: oki y. Blood. 2007 Jan 1;109(1):52-7. doi: 10.1182/blood-2006-05-021162. Epub 2006 Aug 1. Blood. 2007. PMID: 16882708 Clinical Trial.
Decitabine--bedside to bench.
Oki Y, Aoki E, Issa JP. Oki Y, et al. Crit Rev Oncol Hematol. 2007 Feb;61(2):140-52. doi: 10.1016/j.critrevonc.2006.07.010. Epub 2006 Oct 4. Crit Rev Oncol Hematol. 2007. PMID: 17023173 Review.
Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma.
Oki Y, McLaughlin P, Fayad LE, Pro B, Mansfield PF, Clayman GL, Medeiros LJ, Kwak LW, Srivastava PK, Younes A. Oki Y, et al. Cancer. 2007 Jan 1;109(1):77-83. doi: 10.1002/cncr.22389. Cancer. 2007. PMID: 17133412
Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia.
Oki Y, Kantarjian HM, Gharibyan V, Jones D, O'brien S, Verstovsek S, Cortes J, Morris GM, Garcia-Manero G, Issa JP. Oki Y, et al. Cancer. 2007 Mar 1;109(5):899-906. doi: 10.1002/cncr.22470. Cancer. 2007. PMID: 17236224 Clinical Trial.
A parallel phase I/II clinical trial design for combination therapies.
Huang X, Biswas S, Oki Y, Issa JP, Berry DA. Huang X, et al. Among authors: oki y. Biometrics. 2007 Jun;63(2):429-36. doi: 10.1111/j.1541-0420.2006.00685.x. Biometrics. 2007. PMID: 17688495
514 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback